AnalystsCorinne JohnsonCorinne Johnson's Stock Forecasts
AnalystsCorinne Johnson
Sectors:
Analyst Ranking
Top 32%
#1600 out of 5096 analysts
Average Return
+13.37%
Win Rate
46%6 out of 13
Risk vs Reward
Poor
Good
Corinne Johnson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Avidity Biosciences IncRNA | +121.93% | $31.47 | $69.84 | 2025-07-09 - 2025-11-07 | Strong Buy |
Amylyx Pharmaceuticals IncAMLX | +66.58% | $7.39 | $12.31 | 2025-07-09 - 2025-11-07 | Strong Buy |
Syndax Pharmaceuticals IncSNDX | +53.16% | $9.82 | $15.04 | 2025-07-09 - 2025-11-07 | Strong Buy |
Arrivent Biopharma IncAVBP | +31.41% | $20.63 | $27.11 | 2024-02-19 - 2025-02-19 | Strong Buy |
Neurocrine Biosciences IncNBIX | +12.93% | $134.92 | $152.37 | 2025-07-09 - 2025-11-07 | Strong Buy |
Corinne Johnson Analyst Color
Get additional color on Corinne Johnson's coverage of popular stocks
Corinne Johnson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Amylyx Pharmaceuticals IncAMLX | 2 | Strong Buy | $20.00 | +62.47% | Maintains | 2 months ago |
Syndax Pharmaceuticals IncSNDX | 2 | Strong Buy | $24.00 | +59.57% | Maintains | 2 months ago |
Avidity Biosciences IncRNA | 2 | Strong Buy | $55.00 | -21.25% | Reinstates | 4 months ago |
Arrivent Biopharma IncAVBP | 3 | Strong Buy | $33.00 | +82.88% | Reinstates | 4 months ago |
Neurocrine Biosciences IncNBIX | 1 | Strong Buy | $182.00 | +19.45% | Initiates Coverage On | 4 months ago |
Cg Oncology IncCGON | 3 | Strong Buy | $50.00 | N/A | Upgrades | a year ago |
Immunovant IncIMVT | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.